Korro Bio KRRO
NASDAQ KRRO
$9.71 -0.20 (-2.02%)
At close: Oct 1, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Korro Bio (KRRO) reported Depreciation & Amortization (CF) of $400,000 for Q2 2026, down 66.7% from $1.2 million a year earlier and unchanged from the prior quarter.

Analysis

Korro Bio (KRRO) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Korro Bio's Depreciation & Amortization (CF) came in at $2.67 million, down 42.1% year-over-year; for FY2025, it was $4.3 million, up 19.4% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 30.3% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $3.6 million in FY2024 (-0.8%), $3.63 million in FY2023 (+44.6%), $2.51 million in FY2022 (-9.5%) and $2.78 million in FY2021 (+142.1%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $385,000 in Q3 2023 and a high of $1.29 million in Q4 2024.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last three quarters, with growth averaging 19.5% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q3 2021 (growth of 144.2%); the low point was Q1 2026 (a decline of 67.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $400,000 (Q1 2026), $669,000 (Q4 2025) and $1.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Korro Bio 145.73 Mn -250.91 Mn - 400,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 400,000.00
Mar 31, 2026 400,000.00
Dec 31, 2025 669,000.00
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 1.23 Mn
Dec 31, 2024 1.29 Mn
Sep 30, 2024 900,000.00
Jun 30, 2024 700,000.00
Mar 31, 2024 726,000.00
Dec 31, 2023 985,000.00
Sep 30, 2023 385,000.00
Jun 30, 2023 494,000.00
Mar 31, 2023 809,000.00
Dec 31, 2022 417,000.00
Sep 30, 2022 679,000.00
Jun 30, 2022 689,000.00
Mar 31, 2022 726,000.00
Dec 31, 2021 737,000.00
Sep 30, 2021 735,000.00
API Access

Korro Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KRRO&period=max&api_key=YOUR_API_KEY